|Symbol||Name||Last Price||Change||% Change||Day Low||Day High|
Click to View Charting
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise. Open Orphan is listed on both the London and Dublin stock exchanges.
Arden Partners, Davy